Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease

被引：2

作者：

Rambaldi, Benedetta ^{[1
,2
,3
]}

Reynolds, Carol ^{[1
,2
]}

Rai, Sharmila Chamling ^{[1
,2
]}

Asano, Takeru ^{[1
,2
]}

Arihara, Yohei ^{[1
,2
]}

Gooptu, Mahasweta ^{[1
,2
]}

Koreth, John ^{[1
,2
]}

Cutler, Corey ^{[4
]}

Nikiforow, Sarah ^{[1
,2
]}

Ho, Vincent T. ^{[1
,2
]}

Alyea, Edwin P., III ^{[5
]}

Antin, Joseph H. ^{[1
]}

Romee, Rizwan ^{[1
]}

Soiffer, Robert J. ^{[6
,7
]}

Russo, Domenico ^{[3
]}

Ampudia, Jeanette ^{[8
]}

Ng, Cherie Tracy ^{[8
]}

Connelly, Stephen ^{[8
]}

Ritz, Jerome ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Hematol Malignancies, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Univ Brescia, Dpt Clin & Expt Sci, ASST Spedali Civili Brescia, Chair Hematol,Bone Marrow Transplant Unit, Brescia, Italy

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[6] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[7] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[8] Equillium Inc, La Jolla, CA USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-125721

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4517

引用

页数：4

共 50 条

[1] TARGETING THE CD6-ALCAM T CELL COSTIMULATORY PATHWAY AFTER ALLOGENEIC CELL TRANSPLANTATION FOR ACUTE GRAFT VERSUS HOST DISEASE (AGVHD) TREATMENT USING ANTI-CD6 MONOCLONAL ANTIBODY ITOLIZUMAB
Rambaldi, B.
Kim, H. T.
Arihara, Y.
Asano, T.
Reynolds, C.
Manter, M.
Halpern, M.
Weber, A.
Koreth, J.
Cutler, C.
Gooptu, M.
Nikiforow, S.
Ho, V. T.
Antin, J. H.
Romee, R.
Ampudia, J.
Ng, C.
Connelly, S.
Soiffer, R. J.
Ritz, J.
HAEMATOLOGICA, 2022, 107 : 55 - 55
[2] Early Reconstitution of CD6+T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab
Rambaldi, Benedetta
Kim, Haesook T.
Reynolds, Carol
Chamling, Sharmila
Asano, Takeru
Arihara, Yohei
Gooptu, Mahasweta
Koreth, John
Cutler, Corey
Nikiforow, Sarah
Ho, Vincent T.
Antin, Joseph H.
Romee, Rizwan
Soiffer, Robert J.
Ampudia, Jeanette
Ng, Cherie Tracy
Connelly, Stephen
Ritz, Jerome
BLOOD, 2020, 136
[3] Anti-CD6 humanized monoclonal antibody itolizumab, halts disease progression and severity of acute respiratory distress syndrome in COVID-19 disease: A case study
Thacker, Hemant P.
Dhekane, Amit
Wadhwa, Nivedita
Patil, Shalaka
INDIAN JOURNAL OF RESPIRATORY CARE, 2021, 10 (01) : 112 - 115
[4] Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody
Hatano, Ryo
Ohnuma, Kei
Yamamoto, Junpei
Dang, Nam H.
Yamada, Taketo
Morimoto, Chikao
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 263 - 277
[5] Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease
Koreth, John
Ritz, Jerome
Chinn, Leslie
Ng, Cherie
Acevedo, Lisette M.
Chu, Dalena
Fung, Maple
Rothman, Joel
Connelly, Stephen
Thomas, Dolca
Cutler, Corey
BLOOD, 2021, 138
[6] Preliminary Safety and Efficacy of Itolizumab, A Novel Targeted Anti-cd6 Therapy, In Newly Diagnosed Severe Acute Graft-versus-host Disease: Interim Results from The Equate Study
Koreth, John
Loren, Alison W.
Nakamura, Ryotaro
Mielcarek, Marco
Wang, Trent P.
Chen, George L.
Anand, Sarah
Waller, Edmund K.
Pidala, Joseph A.
Meyers, Gabrielle
Hoda, Daanish
Schroeder, Mark A.
Farhadfar, Nosha
Pantin, Jeremy
Ng, Cherie T.
Acevedo, Lisette M.
Fung, Maple
Rothman, Joel
Connelly, Stephen
Polu, Krishna
Cutler, Corey
BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 369 - 371
[7] Preliminary Safety and Efficacy of Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Severe Acute Graft-Versus-Host Disease: Interim Results From the EQUATE Study
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 12 - 13
[8] TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH A NONMITOGENIC ANTI-CD3 MONOCLONAL-ANTIBODY
ANASETTI, C
MARTIN, PJ
STORB, R
APPELBAUM, FR
BEATTY, PG
DAVIS, J
DONEY, K
HILL, HF
STEWART, P
SULLIVAN, KM
WITHERSPOON, RP
THOMAS, ED
HANSEN, JA
TRANSPLANTATION, 1992, 54 (05) : 844 - 851
[9] Treatment of steroid resistant acute graft versus host disease with an ANTI-CD26 Monoclonal antibody - Begelomab
Metafuni, Elisabetta
Gualandi, Francesca
Raiola, Anna Maria
Varaldo, Riccardo
Di Grazia, Carmen
Angelucci, Emanuele
Benedetti, Edoardo
Locatelli, Franco
Risitano, Antonio
Musso, Maurizio
Zallio, Francesco
Ciceri, Fabio
Chiusolo, Patrizia
Rambaldi, Alessandro
Bonifazi, Francesca
Parma, Matteo
Martino, Massimo
Onida, Francesco
Iori, Anna Paola
Selleri, Carmine
Borghero, Carlo
Bertaina, Alice
Van Lint, Maria Teresa
Bacigalupo, Andrea
BONE MARROW TRANSPLANTATION, 2019, 54 : 83 - 83
[10] Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab
Andrea Bacigalupo
Emanuele Angelucci
Anna Maria Raiola
Riccardo Varaldo
Carmen Di Grazia
Francesca Gualandi
Edoardo Benedetti
Antonio Risitano
Maurizio Musso
Francesco Zallio
Fabio Ciceri
Patrizia Chiusolo
Simona Sica
Alessandro Rambaldi
Francesca Bonifazi
Matteo Parma
Massimo Martino
Francesco Onida
Anna Paola Iori
Carmine Selleri
Carlo Borghero
Alice Bertaina
Lucia Prezioso
Mattia Algeri
Franco Locatelli
Bone Marrow Transplantation, 2020, 55 : 1580 - 1587

← 1 2 3 4 5 →